PERTH, Australia – Sydney-based Pharmaxis Ltd. announced a capital raising of A$24 million (US$17.3 million) to ready itself for another partnering play. The funds will be raised in a two-tranche placement of 73.4 million ordinary shares priced at A32 cents per share.